Effect of Periodontal Therapy on Asprosin in Stable Angina
Effect of Non-Surgical Periodontal Therapy on Serum Asprosin in Patients With Stable Angina
研究概览
详细说明
Periodontitis is a chronic inflammatory disease characterized by the destruction of the tooth-supporting tissues and has been associated with increased systemic inflammation and cardiovascular diseases. Stable angina, a clinical manifestation of coronary artery disease, is closely linked to inflammatory and metabolic pathways. Increasing evidence suggests that periodontal inflammation may contribute to cardiovascular pathology through systemic dissemination of inflammatory mediators and oxidative stress mechanisms.
Asprosin is a recently identified adipokine secreted mainly from white adipose tissue and is involved in glucose metabolism, inflammatory regulation, and cardiovascular homeostasis. Previous studies have reported altered serum asprosin levels in patients with atherosclerosis, myocardial infarction, and periodontitis. However, the effect of periodontal therapy on serum asprosin levels in patients with stable angina has not yet been clinically investigated.
In this clinical study, 60 individuals will be allocated into three groups: healthy controls, periodontitis patients, and patients with stable angina and periodontitis. Non-surgical periodontal therapy will be performed in periodontitis groups, while supragingival scaling and oral hygiene instructions will be provided for controls. Clinical periodontal parameters and serum asprosin levels will be evaluated at baseline and at 3-month follow-up using ELISA analysis.
The study aims to determine whether periodontal therapy may influence serum asprosin levels and to evaluate the possible relationship between periodontal inflammation and metabolic-inflammatory pathways in cardiovascular disease. To the best of our knowledge, this is the first clinical study evaluating the effect of periodontal therapy on serum asprosin levels in patients with stable angina.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Sena Altintas, DDS
- 电话号码:+905540270097
- 邮箱:senaltintas144@gmail.com
研究联系人备份
- 姓名:Feyza Otan Ozden, Prof.
- 邮箱:feyza_otan@yahoo.com
学习地点
-
-
Atakum
-
Samsun、Atakum、土耳其(türkiye)、55270
- Ondokuz Mayis University
-
接触:
- Ondokuz Mayis University Faculty of Dentistry
- 电话号码:+90362 312 19 19 / 8121
- 邮箱:disinfo@omu.edu.tr
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Willingness to participate in the study and provide written informed consent
- Age 18 years or older
- No periodontal treatment within the past 6 months
- No use of local or systemic antibiotics within the past 3 months
Exclusion Criteria:
- Unwillingness to participate in the study or to provide informed consent
- Age under 18 years
- Use of local or systemic antibiotics for the treatment of widespread infection within the past 3 months
- Receipt of periodontal treatment within the past 6 months
- Pregnancy or lactation (for female participants)
- History of acute myocardial infarction within the past 6 months
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Stable angina and periodontitis group (SAP group)
Individuals with angiographically confirmed stable angina and periodontitis who will receive non-surgical periodontal therapy, including scaling and root planing
|
非手术牙周治疗将包括全口洁治和根面平整,使用手动器械和/或超声设备去除龈上及龈下菌斑和牙结石。
|
|
实验性的:Periodontitis group (P group)
Individuals with angiographically confirmed cardiovascular health and periodontitis who will receive non-surgical periodontal therapy, including scaling and root planing
|
非手术牙周治疗将包括全口洁治和根面平整,使用手动器械和/或超声设备去除龈上及龈下菌斑和牙结石。
|
|
有源比较器:Control group (C group)
Periodontally healthy individuals with angiographically confirmed absence of coronary artery disease who will receive routine professional dental cleaning and standardized oral hygiene instruction
|
通过标准化的口腔卫生指导去除龈上牙石和菌斑。
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in serum asprosin levels after non-surgical periodontal therapy
大体时间:Baseline and 3 months
|
Serum asprosin concentrations (ng/mL) will be measured using a commercially available enzyme-linked immunosorbent assay (ELISA) kit at baseline and 3 months following non-surgical periodontal therapy.
|
Baseline and 3 months
|
合作者和调查者
调查人员
- 首席研究员:Sena Altintas, DDS、Ondokuz Mayis University Department of Periodontology
- 研究主任:Feyza Otan Ozden, Prof.、Ondokuz Mayis University Department of Periodontology
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- OMU-306
- 5673 (其他赠款/资助编号:Grantor or Funder Organization: Ondokuz Mayıs University - Scientific Research Projects Coordination Unit (BAP))
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.